180 related articles for article (PubMed ID: 11853934)
1. Enhanced tumor cell selectivity of adriamycin-monoclonal antibody conjugate via a poly(ethylene glycol)-based cleavable linker.
Suzawa T; Nagamura S; Saito H; Ohta S; Hanai N; Kanazawa J; Okabe M; Yamasaki M
J Control Release; 2002 Feb; 79(1-3):229-42. PubMed ID: 11853934
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of a novel duocarmycin derivative DU-257 and its application to immunoconjugate using poly(ethylene glycol)-dipeptidyl linker capable of tumor specific activation.
Suzawa T; Nagamura S; Saito H; Ohta S; Hanai N; Yamasaki M
Bioorg Med Chem; 2000 Aug; 8(8):2175-84. PubMed ID: 11003162
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and HPLC analysis of enzymatically cleavable linker consisting of poly(ethylene glycol) and dipeptide for the development of immunoconjugate.
Suzawa T; Nagamura S; Saito H; Ohta S; Hanai N; Yamasaki M
J Control Release; 2000 Oct; 69(1):27-41. PubMed ID: 11018544
[TBL] [Abstract][Full Text] [Related]
4. Legumain-cleavable 4-arm poly(ethylene glycol)-doxorubicin conjugate for tumor specific delivery and release.
Zhou H; Sun H; Lv S; Zhang D; Zhang X; Tang Z; Chen X
Acta Biomater; 2017 May; 54():227-238. PubMed ID: 28315495
[TBL] [Abstract][Full Text] [Related]
5. PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity.
Veronese FM; Schiavon O; Pasut G; Mendichi R; Andersson L; Tsirk A; Ford J; Wu G; Kneller S; Davies J; Duncan R
Bioconjug Chem; 2005; 16(4):775-84. PubMed ID: 16029018
[TBL] [Abstract][Full Text] [Related]
6. Poly(ethylene glycol)-doxorubicin conjugates containing beta-lactamase-sensitive linkers.
Senter PD; Svensson HP; Schreiber GJ; Rodriguez JL; Vrudhula VM
Bioconjug Chem; 1995; 6(4):389-94. PubMed ID: 7578358
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of doxorubicin-monoclonal antibody conjugate on human bladder cancer.
Yu DS; Chu TM; Yeh MY; Chang SY; Ma CP; Han SH
J Urol; 1988 Aug; 140(2):415-21. PubMed ID: 3398165
[TBL] [Abstract][Full Text] [Related]
8. Targeting doxorubicin to epidermal growth factor receptors by site-specific conjugation of C225 to poly(L-glutamic acid) through a polyethylene glycol spacer.
Vega J; Ke S; Fan Z; Wallace S; Charsangavej C; Li C
Pharm Res; 2003 May; 20(5):826-32. PubMed ID: 12751641
[TBL] [Abstract][Full Text] [Related]
9. Anticancer activity of PEGylated matrix metalloproteinase cleavable peptide-conjugated adriamycin against malignant glioma cells.
Lim SH; Jeong YI; Moon KS; Ryu HH; Jin YH; Jin SG; Jung TY; Kim IY; Kang SS; Jung S
Int J Pharm; 2010 Mar; 387(1-2):209-14. PubMed ID: 19945519
[TBL] [Abstract][Full Text] [Related]
10. Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads.
Ojima I
Acc Chem Res; 2008 Jan; 41(1):108-19. PubMed ID: 17663526
[TBL] [Abstract][Full Text] [Related]
11. Efficient clearance of poly(ethylene glycol)-modified immunoenzyme with anti-PEG monoclonal antibody for prodrug cancer therapy.
Cheng TL; Chen BM; Chern JW; Wu MF; Roffler SR
Bioconjug Chem; 2000; 11(2):258-66. PubMed ID: 10725103
[TBL] [Abstract][Full Text] [Related]
12. Optimization of a PEGylated Glucuronide-Monomethylauristatin E Linker for Antibody-Drug Conjugates.
Burke PJ; Hamilton JZ; Jeffrey SC; Hunter JH; Doronina SO; Okeley NM; Miyamoto JB; Anderson ME; Stone IJ; Ulrich ML; Simmons JK; McKinney EE; Senter PD; Lyon RP
Mol Cancer Ther; 2017 Jan; 16(1):116-123. PubMed ID: 28062707
[TBL] [Abstract][Full Text] [Related]
13. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
Chari RV
Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
[TBL] [Abstract][Full Text] [Related]
14. Optimizing Lysosomal Activation of Antibody-Drug Conjugates (ADCs) by Incorporation of Novel Cleavable Dipeptide Linkers.
Salomon PL; Reid EE; Archer KE; Harris L; Maloney EK; Wilhelm AJ; Miller ML; Chari RVJ; Keating TA; Singh R
Mol Pharm; 2019 Dec; 16(12):4817-4825. PubMed ID: 31609629
[TBL] [Abstract][Full Text] [Related]
15. Acid-sensitive polyethylene glycol conjugates of doxorubicin: preparation, in vitro efficacy and intracellular distribution.
Rodrigues PC; Beyer U; Schumacher P; Roth T; Fiebig HH; Unger C; Messori L; Orioli P; Paper DH; Mülhaupt R; Kratz F
Bioorg Med Chem; 1999 Nov; 7(11):2517-24. PubMed ID: 10632061
[TBL] [Abstract][Full Text] [Related]
16. New hydrazone derivatives of adriamycin and their immunoconjugates--a correlation between acid stability and cytotoxicity.
Kaneko T; Willner D; Monkovíc I; Knipe JO; Braslawsky GR; Greenfield RS; Vyas DM
Bioconjug Chem; 1991; 2(3):133-41. PubMed ID: 1932212
[TBL] [Abstract][Full Text] [Related]
17. Specific binding of sterically stabilized anti-B-cell immunoliposomes and cytotoxicity of entrapped doxorubicin.
Lundberg BB; Griffiths G; Hansen HJ
Int J Pharm; 2000 Sep; 205(1-2):101-8. PubMed ID: 11000546
[TBL] [Abstract][Full Text] [Related]
18. Specific Conjugation of the Hinge Region for Homogeneous Preparation of Antibody Fragment-Drug Conjugate: A Case Study for Doxorubicin-PEG-anti-CD20 Fab' Synthesis.
Zhou Z; Zhang J; Zhang Y; Ma G; Su Z
Bioconjug Chem; 2016 Jan; 27(1):238-46. PubMed ID: 26700095
[TBL] [Abstract][Full Text] [Related]
19. Reduction-responsive disassemblable core-cross-linked micelles based on poly(ethylene glycol)-b-poly(N-2-hydroxypropyl methacrylamide)-lipoic acid conjugates for triggered intracellular anticancer drug release.
Wei R; Cheng L; Zheng M; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2012 Aug; 13(8):2429-38. PubMed ID: 22746534
[TBL] [Abstract][Full Text] [Related]
20. Preparation and cytotoxic activity of poly(ethylene glycol)-modified poly(amidoamine) dendrimers bearing adriamycin.
Kono K; Kojima C; Hayashi N; Nishisaka E; Kiura K; Watarai S; Harada A
Biomaterials; 2008 Apr; 29(11):1664-75. PubMed ID: 18194811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
